Showing results (2551-2560 of 2,614) with videos related to

Sort By:
Pageof 262
Circulation. Cardiovascular Interventions|December 17, 2024
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA TrialHarmony R Reynolds, Courtney B Page, Leslee J Shaw, et al.
Science Translational Medicine|April 5, 2019
Using fMRI connectivity to define a treatment-resistant form of post-traumatic stress disorderAmit Etkin, Adi Maron-Katz, Wei Wu, et al.
The New England Journal of Medicine|June 13, 2019
Clinical Metagenomic Sequencing for Diagnosis of Meningitis and EncephalitisMichael R Wilson, Hannah A Sample, Kelsey C Zorn, et al.
The New England Journal of Medicine|April 28, 2025
Nonoperative Management of Mismatch Repair-Deficient TumorsAndrea Cercek, Michael B Foote, Benoit Rousseau, et al.
Systems Medicine (New Rochelle, N.Y.)|April 1, 2020
Recent Advances in Systems and Network Medicine: Meeting Report from the First International Conference in Systems and Network MedicineEmma Kurnat-Thoma, Ancha Baranova, Pat Baird, et al.
Frontiers in Neurology|April 1, 2022
Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis ApproachAnna G Mayhew, Meredith K James, Ursula Moore, et al.
Journal of the Pediatric Infectious Diseases Society|November 8, 2024
Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal NetworkRobert F T Bucayu, Craig L K Boge, Inci Yildirim, et al.
Annals of Neurology|February 12, 2021
Assessing Dysferlinopathy Patients Over Three Years With a New Motor ScaleMarni B Jacobs, Meredoith K James, Linda P Lowes, et al.
Nature Medicine|August 15, 2022
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim resultsChristine D Palmer, Amy R Rappaport, Matthew J Davis, et al.
Cancer Cell|October 24, 2025
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.
Pageof 262